Is any association between alternate healthy eating index (AHEI) with lipid profile and liver enzymes? A cross-sectional Study

[1] Moravejolahkami AR(2019)Dietary intake of energy and fiber in MS patients; an approach to prebiotics role Nutr Food Sci 49 1039-1050

[2] Paknahad Z(2021)The associations between dietary pattern of chronic obstructive pulmonary disease patients and depression: a cross-sectional study BMC Pulm Med 21 1-8

[3] Chitsaz A(2021)Therapies for the treatment of cardiovascular disease associated with Type 2 diabetes and dyslipidemia Int J Mol Sci 22 660-12

[4] Dinparast F(2021)The effect of probiotics on lipid profile and anthropometric indices in diabetic nephropathy; a systematic review and meta-analysis of clinical trials J Diabetes Metab Disord 20 1-547

[5] Sharifi A(1998)Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease East Mediterr Health J 4 539-39

[6] Moradi S(2021)Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults Ren Fail 43 32-84

[7] Alipour M(2016)Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-110

[8] Alipour B(2016)Prevalence of non-alcoholic fatty liver disease and its related factors in Iran Int J Organ Transplant Med 7 149-12

[9] Aguilar-Ballester M(2021)Current treatment paradigms and emerging therapies for NAFLD/NASH Front Biosci (Landmark Ed.) 26 206-1231

[10] Hurtado-Genovés G(2021)Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease Diagnostics 11 98-157

[1] Moravejolahkami AR(2019)Dietary intake of energy and fiber in MS patients; an approach to prebiotics role Nutr Food Sci 49 1039-1050

[2] Paknahad Z(2021)The associations between dietary pattern of chronic obstructive pulmonary disease patients and depression: a cross-sectional study BMC Pulm Med 21 1-8

[3] Chitsaz A(2021)Therapies for the treatment of cardiovascular disease associated with Type 2 diabetes and dyslipidemia Int J Mol Sci 22 660-12

[4] Dinparast F(2021)The effect of probiotics on lipid profile and anthropometric indices in diabetic nephropathy; a systematic review and meta-analysis of clinical trials J Diabetes Metab Disord 20 1-547

[5] Sharifi A(1998)Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease East Mediterr Health J 4 539-39

[6] Moradi S(2021)Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults Ren Fail 43 32-84

[7] Alipour M(2016)Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-110

[8] Alipour B(2016)Prevalence of non-alcoholic fatty liver disease and its related factors in Iran Int J Organ Transplant Med 7 149-12

[9] Aguilar-Ballester M(2021)Current treatment paradigms and emerging therapies for NAFLD/NASH Front Biosci (Landmark Ed.) 26 206-1231

[10] Hurtado-Genovés G(2021)Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease Diagnostics 11 98-157